EichorEICHOR
Location: Palo Alto Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Palo Alto

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

TBI Rehabilitation and Activation in Veterans
NA · VA Palo Alto Health Care System · Northern California Institute of Research and Education · NCT06562127Randomized Trial of SGLT2i in Heart Transplant Recipients
Phase 4 · VA Palo Alto Health Care System, Palo Alto, CA · VA Office of Research and Development · NCT06625073Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
Phase N/A · Parkinson's Research Centers of America - Palo Alto · Supernus Pharmaceuticals, Inc. · NCT07219927Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Palo Alto Center-Palo Alto Medical Foundation Research Insti · Bristol-Myers Squibb · NCT07106762Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Palo Alto Medical Foundation Health Care · NRG Oncology · NCT05624996Prehabilitation and Rehabilitation in PAD
NA · VA Palo Alto Health Care System · Palo Alto Veterans Institute for Research · NCT06566976A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Palo Alto Medical Foundation Research Center · Hoffmann-La Roche · NCT06793215Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
Phase N/A · Stanford Cancer Institute Palo Alto · PrECOG, LLC. · NCT06538038Repletion of Ergothioneine in Patients With Kidney Failure
NA · Veterans Affairs Palo Alto · Stanford University · NCT06487546CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
NA · VA Palo Alto Health Care System, Palo Alto, CA · VA Office of Research and Development · NCT05996328Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Palo Alto Medical Foundation Health Care · NRG Oncology · NCT05174169Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing
NA · Veteran Affairs Palo Alto Health Care System · University of British Columbia · NCT04634240Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia o
Phase 2 · Stanford Cancer Institute Palo Alto · Mayo Clinic · NCT05388006ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Stanford Cancer Institute Palo Alto · Alliance for Clinical Trials in Oncology · NCT06876714Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SL
Phase 3 · Stanford Cancer Institute Palo Alto · National Cancer Institute (NCI) · NCT04269902Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Stanford Cancer Institute Palo Alto · Canadian Cancer Trials Group · NCT06592924Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee
Phase N/A · VA Palo Alto Healthcare System · Palo Alto Veterans Institute for Research · NCT05700682Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
Phase N/A · VA Palo Alto Health Care System · Palo Alto Veterans Institute for Research · NCT07303712Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NI
Phase 1 · Stanford Cancer Institute Palo Alto · National Cancer Institute (NCI) · NCT03816345Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely
Phase 3 · Stanford Cancer Institute Palo Alto · NRG Oncology · NCT03180268Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
NA · VA Palo Alto Health Care System, Palo Alto, CA · VA Office of Research and Development · NCT06033924A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson'
Phase 3 · Parkinson?s Research Centers of America ? Palo Alto · Hoffmann-La Roche · NCT07174310An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
Phase 3 · VA Palo Alto Health Care System · Novartis Pharmaceuticals · NCT05939414Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carci
Phase 3 · Stanford Cancer Institute Palo Alto · National Cancer Institute (NCI) · NCT05256225A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Se
Phase N/A · Stanford Cancer Institute Palo Alto · City of Hope Medical Center · NCT07003100Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With G
Phase 2/Phase 3 · Stanford Cancer Institute Palo Alto · ECOG-ACRIN Cancer Research Group · NCT07001748SMART Therapist Training: A Hybrid Factorial-SMART Design
NA · VA Palo Alto Health Care System, Palo Alto, CA · VA Office of Research and Development · NCT07010770Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult
Phase 3 · Palo Alto Medical Foundation - Palo Alto Center · Pfizer · NCT07222800Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Phase 3 · Palo Alto Medical Foundation Health Care · ECOG-ACRIN Cancer Research Group · NCT04566328De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Palo Alto Medical Foundation Health Care · NRG Oncology · NCT04852887
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.